anti-CD45RB antibody product blog
Tags: Antibody; Monoclonal Antibody; CD45RB; anti-CD45RB antibody;
The CD45RB n/a (Catalog #MBS2400786) is an Antibody produced from Mouse and is intended for research purposes only. The product is available for immediate purchase. The Anti-CD45RB Antibody (clone PD7/26) reacts with Human and may cross-react with other species as described in the data sheet. MyBioSource\'s CD45RB can be used in a range of immunoassay formats including, but not limited to, Immunohistochemistry (IHC) Paraffin.IHC-P: 10 ug/ml. Researchers should empirically determine the suitability of the CD45RB n/a for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Please refer to the product datasheet for known applications of a given antibody. We\'ve tested the Anti-CD45RB Antibody (clone PD7/26) with the following immunoassay(s):
Immunohistochemistry (IHC) (Anti-CD45RB antibody IHC of human spleen. Immunohistochemistry of formalin-fixed, paraffin-embedded tissue after heat-induced antigen retrieval. Antibody dilution 10 ug/ml.)
phosphatase, receptor type, C also known as PTPRC is an enzyme that, inhumans, is encoded by the PTPRC gene. PTPRC is also known as CD45antigen (CD stands for cluster of differentiation), which was originallycalled leukocyte common antigen (LCA). the CD45 family consists ofmultiple members that are all products of a single complex gene.
Immunogen: Human peripheral blood lymphocytes maintained in T cell growth factor.
Conjugation: Unconjugated. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing CD45RB are readily searchable from our website. Different antibodies against the same target such as CD45RB may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.